Artificial intelligence and mRNA vaccine bring hope in dog's cancer treatment
An Australian entrepreneur developed a custom mRNA vaccine against his dog's mast cell cancer using artificial intelligence tools and achieved great success.
Australian tech entrepreneur Paul Conyngham developed a personalized mRNA vaccine against his dog Rosie's mast cell cancer by utilizing artificial intelligence tools such as ChatGPT, Gemini, and Grok, along with university scientists. This success, which resulted in a 75 percent tumor reduction, has generated widespread resonance around the world.
Cancer Diagnosis and Search for Treatment
In May 2024, tech entrepreneur Paul Conyngham's dog, Rosie, was diagnosed with mast cell cancer in Australia. When standard treatments proved ineffective, the entrepreneur refused to give up and sought a new path with the support of artificial intelligence.
AI-Powered mRNA Vaccine
Using AI tools like ChatGPT, Gemini, and Grok, the dog's genomic data was analyzed in detail. As a result of these analyses, teams from the University of New South Wales and the Garvan Institute identified mutations in the tumor and designed a custom mRNA vaccine.
Success of the Treatment
Rosie received her first injection in December 2025, and three months later, a significant reduction was observed in the tumors on her legs. The experimental initiative achieved a 75 percent reduction in the tumor and prolonged the dog's life expectancy.
Caught the Attention of Sam Altman
The processing of massive amounts of data by AI models during the vaccine development process also caught the attention of OpenAI CEO Sam Altman. Altman met with the entrepreneur, stating that this work was carried out with the power of a standalone research institute.
Birth of a New Startup
Paul Conyngham founded a startup named Gamgee to make similar processes accessible for other patients. This venture works toward developing treatments tailored to each patient on a large scale.
Comments from the Scientific World and Politicians
Prof. Pall Thordarson, Director of the UNSW RNA Institute, stated that artificial intelligence accelerates the design process and reduces errors. U.S. Health Secretary Robert F. Kennedy Jr. stated that such innovations will be seen in every field of medicine.